HomePYXS • NASDAQ
add
Pyxis Oncology Inc
Previous close
$2.96
Day range
$3.03 - $3.08
Year range
$1.35 - $6.85
Market cap
181.38M USD
Avg Volume
709.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 16.15M | — |
Operating expense | 20.48M | -2.10% |
Net income | -3.26M | 83.08% |
Net profit margin | -20.17 | — |
Earnings per share | -0.06 | 88.89% |
EBITDA | -3.69M | 82.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 157.03M | 5.14% |
Total assets | 220.22M | 20.47% |
Total liabilities | 36.06M | 17.70% |
Total equity | 184.16M | — |
Shares outstanding | 58.89M | — |
Price to book | 0.95 | — |
Return on assets | -6.10% | — |
Return on capital | -6.83% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -3.26M | 83.08% |
Cash from operations | -20.71M | 22.84% |
Cash from investing | -18.50M | 81.39% |
Cash from financing | 57.51M | — |
Net change in cash | 18.30M | 114.50% |
Free cash flow | -19.26M | 41.94% |
About
Founded
2018
Headquarters
Website
Employees
51